These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 5935822)

  • 1. [Recent acquisitions in cancer chemotherapy].
    Amiel JL; Bernard J; Bessis M; Dreyfus B; Najean Y; Seligmann M; Péquignot H
    Presse Med (1893); 1966 Jun; 74(32):1683-6. PubMed ID: 5935822
    [No Abstract]   [Full Text] [Related]  

  • 2. [Observations on the use of a recent antineoplastic drug (methylhydrazine) associated with radiotherapy].
    Agati G
    Minerva Radiol; 1968 Sep; 13(9):470-8. PubMed ID: 5726968
    [No Abstract]   [Full Text] [Related]  

  • 3. [Segidrin: a new-type antineoplastic agent].
    Filov VA
    Vopr Onkol; 1994; 40(1-3):3-14. PubMed ID: 7701790
    [No Abstract]   [Full Text] [Related]  

  • 4. Unconventional therapies for cancer: 4. Hydrazine sulfate. Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.
    Kaegi E
    CMAJ; 1998 May; 158(10):1327-30. PubMed ID: 9614826
    [No Abstract]   [Full Text] [Related]  

  • 5. [Recent cytostatic therapy in hemoblastosis and malignant tumors].
    Kühböck J; Mannheimer E
    Wien Klin Wochenschr; 1966 Jul; 78(26):487-8. PubMed ID: 5992456
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacologic aspects of the chemotherapy of solid tumors.
    DeVita VT; Rall DP
    Pharmacol Physicians; 1968 Sep; 2(9):1-6. PubMed ID: 5743792
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical observations on the short-term effects of a synthetic antiblastic agent, a derivative of methylhydrazine, with or without radiotherapy].
    Massenti S; Perri G
    Minerva Radiol; 1967 Apr; 12(4):140-4. PubMed ID: 5613803
    [No Abstract]   [Full Text] [Related]  

  • 8. Supportive care drug studies: some promising, some not.
    Oncology (Williston Park); 1992 Sep; 6(9):93-4. PubMed ID: 1333264
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug therapy of cancer cachexia].
    Ovesen LF
    Ugeskr Laeger; 1994 Jan; 156(2):203-6. PubMed ID: 8296415
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experiences with a new cytostatic of the methylhydrazine series (Natulan). With special reference to hematological side-effects].
    Kummer H; Bucher U
    Schweiz Med Wochenschr; 1965 Sep; 95(37):1233-40. PubMed ID: 5863643
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecule of the month. Elesclomol and obatoclax mesylate.
    Drug News Perspect; 2008 Mar; 21(2):123-4. PubMed ID: 18389103
    [No Abstract]   [Full Text] [Related]  

  • 12. 1-acetyl-2-picolinoylhydrazine (NSC-68626) in the treatment of advanced cancer.
    Olson KB; Horton J; Pratt KL; Paladine WJ; Cunningham T; Sullivan J; Hosley H; Treble DH
    Cancer Chemother Rep; 1969 Oct; 53(5):291-6. PubMed ID: 5377616
    [No Abstract]   [Full Text] [Related]  

  • 13. Hydrazine sulfate in the treatment of cancer.
    Gold J
    Cancer Treat Rep; 1976 Jul; 60(7):964-5. PubMed ID: 1009532
    [No Abstract]   [Full Text] [Related]  

  • 14. Three stakes in hydrazine sulfate's heart, but questionable cancer remedies, like vampires, always rise again.
    Herbert V
    J Clin Oncol; 1994 Jun; 12(6):1107-8. PubMed ID: 8201370
    [No Abstract]   [Full Text] [Related]  

  • 15. Reactive oxygen species may have antitumor activity in metastatic melanoma.
    Tuma RS
    J Natl Cancer Inst; 2008 Jan; 100(1):11-2. PubMed ID: 18159075
    [No Abstract]   [Full Text] [Related]  

  • 16. Unconventional therapies and cancer.
    Bégin M; Kaegi E
    CMAJ; 1999 Sep; 161(6):686-7. PubMed ID: 10513271
    [No Abstract]   [Full Text] [Related]  

  • 17. [Polychemotherapy of cancer. Preliminary study concerning 82 cases, of which 76 are cases of cancer of stomatologic origin].
    Jacquillat C; Szpirglas H; Weil M; Levy D; Crépy C; Cernéa P; Bernard J
    Presse Med (1893); 1967 May; 75(26):1321-4. PubMed ID: 6026559
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of 2-(methylaminosulfonyl)-1-(arylsulfonyl)hydrazines as anticancer agents.
    Ghosh M; Dutta S; Sanyal U
    Neoplasma; 1999; 46(4):242-5. PubMed ID: 10613605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A fundamentally new cytostatic: a methylhydrazine derivative (Natulan)].
    Hansen MM; Hertz H
    Ugeskr Laeger; 1966 Mar; 128(11):313-6. PubMed ID: 5331165
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical experiences with a methylhydrazine derivative (Natulan)].
    Hertz H; Hansen MM; Videbaek AA
    Ugeskr Laeger; 1966 Mar; 128(11):316-24. PubMed ID: 5331015
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.